LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression.

Authors:
Li Y; Mendoza-Castrejon J; Patel RM; Casey EB; Denby E and 2 more

Journal:
Leukemia

Publication Year: 2024

DOI:
10.1038/s41375-024-02167-0

PMCID:
PMC10912017

PMID:
38321106

Journal Information

Full Title: Leukemia

Abbreviation: Leukemia

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"rna-sequencing data are available in gene expression omnibus (gse253725). data availability the datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request. rna-sequencing data are available in gene expression omnibus (gse253725"

Code Sharing
Evidence found in paper:

"Competing interests The authors declare no competing interests."

Evidence found in paper:

"This work was supported by grants to JAM from the NHLBI (R01HL152180 and R01HL136504), Alex’s Lemonade Stand Foundation (‘A’ Award), and the Children’s Discovery Institute of Washington University and St. Louis Children’s Hospital. JAM is a Leukemia and Lymphoma Society Scholar. JM-C is funded by an NCI career development grant (F31CA268923). DB holds grants from the Swedish Cancer and Pediatric Cancer Societies."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025